If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: Vectura And MJ Gleeson CEOs Leave

Mon, 10th Jun 2019 07:41

LONDON (Alliance News) - Stock prices in London are seen opening higher on Monday after US President Donald Trump suspended his plans for tariffs on Mexico, while hopes of lower US interest rates also lifted investor sentiment.In early UK company news, Ferguson will launch a USD500 million share buyback programme. Vectura's chief executive stepped down. MJ Gleeson's CEO also departed amid a row over remuneration. IG futures indicate the FTSE 100 index is to open 35.46 points higher at 7,367.40. The blue chip index closed up 72.09 points, or 1.0%, at 7,331.94 on Friday.On Friday, Trump said he would not impose the 5% tariff on Mexican imports as he had threatened, saying a deal had been reached on stemming flows of migrants from Central America.As part of the immigration deal, asylum seekers will be returned to Mexico to await their hearings in US courts. Mexico also has pledged to beef up security on its own southern border.Ferguson reported earnings growth in the third quarter of its current financial year and said that it will deliver annual results in line with market expectations.In addition, the FTSE 100 firm said it has surplus cash beyond its immediate re-investment needs. Therefore, it proposed to buy back USD500 million of shares over the next 12 months.In the past six years, Ferguson has returned USD3.5 billion of surplus cash to shareholders, it noted.The plumbing and heating products distributor reported revenue for the three months to the end of April of USD5.27 billion, up 6.2% from USD4.97 billion reported for the same period a year prior. On an organic basis, revenue climbed by 2.3%. Woodford Patient Capital Trust said it was pleased with the operational progress of its portfolio companies, noting last week's tumultuous events surrounding portfolio manager Woodford Investment Management.Last week, fund manager Neil Woodford's investment management company suspended dealings in its flagship Woodford Equity Income fund after a run of poor performance and rising redemptions. Woodford Patient Capital Trust maintained that it continues to have the potential to deliver attractive returns, in line with the long-term mandate of the company. Further, the operational performance of these businesses "is not impacted by recent events". Chair Susan Searle commented: "The board is closely monitoring the situation and is engaging with its shareholders and advisers. Separately, the board is in regular dialogue with the portfolio manager. The board wishes to emphasise the long-term approach of the company and will continue to keep shareholders updated as necessary."Vectura Group said Chief Executive James Ward-Lilley is to step down from his role and the board of the pharmaceutical company on June 30, without giving a reason. He had been CEO for four years.The company said Chief Financial Officer Paul Fry will assume the role of interim CEO in addition to his current duties as CFO. The search for Ward-Lilley's successor is underway. MJ Gleeson said Jolyon Harrison has stepped down as CEO of the housing regeneration firm with immediate effect over "remuneration and succession planning" matters. The company said it was unable to find acceptable basis for Harrison to continue as CEO. MJ Gleeson said it appointed James Thomson as interim CEO with immediate effect and also re-affirmed guidance to deliver annual results in line with expectations.Aviation services provider John Menzies confirmed a new long-term ground handling contract at London Luton airport from budget airline easyJet.John Menzies will handle 24,000 aircraft turns per annum at Luton for easyJet. "This contract is one of the largest single ground handling contracts in the UK and I am delighted to have secured it. This together with other recent contract gains demonstrates that our renewed focus on our UK business is starting to pay dividends, and I look forward to more progress throughout 2019," said John Menzies CEO Giles Wilson. The Japanese Nikkei 225 closed up 1.2% on Monday. In China, the Shanghai Composite is up 0.7%, while the Hang Seng index in Hong Kong is up 2.1%. Financial markets in China and Hong Kong reopened after being closed for the Dragon Boat Festival on Friday.Japan's economy grew at an annual rate of 2.2% in the January-to-March period, marking the second straight quarter of expansion, despite sluggish consumer spending, a government report showed.The reading was in line with the 2.2% growth forecast by analysts surveyed by the Nikkei Business Daily, and slightly revised up from an initial estimate of 2.1%, the Cabinet Office said.Meanwhile, China's exports rebounded in May, while imports dropped amid a protracted trade war with the US, official data showed.Exports rose 1.1% year-on-year, while imports fell 8.5%, the customs administration said. The trade surplus last month came in at USD41.65 billion, above analysts' expectations.China-US trade continued to fall significantly in May, with Chinese exports to the US dropping 8.4% and imports plunging 30%. Trade negotiations between the two countries have stalled, with Washington threatening to impose fresh tariffs on Chinese goods.In the US on Friday, Wall Street ended higher, with the Dow Jones Industrial Average up 1.0%, S&P 500 up 1.1% and Nasdaq Composite up 1.7%.US stocks rose sharply on Friday as weak jobs data added to expectations that the Federal Reserve may cut US interest rates as soon as July.The pound was quoted at USD1.2704 early Monday, lower than USD1.2760 late Friday.UK retail footfall shrunk in May, hitting the lowest level on record in over six years, with declines experienced in every region and category, the latest BRC/Springboard Retail Footfall Monitor showed Monday.Figures covering the four weeks to May 25, showed a 3.5% drop in total retail footfall on the year before. In the same period a year before, footfall had slipped by just 0.4% on an annual basis.On a three-month basis, footfall decreased 0.7% on a year before, with the six and twelve-month averages both down 1.3% and 1.4% respectively.In the economic events calendar on Monday, there are UK industrial and manufacturing production data at 0930 BST.

More News
18 Dec 2020 08:12

Hikma rallies as it launches generic version of Glaxo asthma treatment

(Sharecast News) - Hikma Pharmaceuticals shares rallied after the company said it had received approval from the US Food and Drug Administration and launched its generic version of GlaxoSmithKline's asthma treatment, Advair Diskus.

Read more
17 Dec 2020 18:10

Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus

Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus

Read more
4 Dec 2020 13:05

IN BRIEF: Tissue Regenix Adds Former Vectura COO To Board

IN BRIEF: Tissue Regenix Adds Former Vectura COO To Board

Read more
30 Nov 2020 09:53

Vectura Inks Agreement To Support Kinaset Therapeutics For Asthma Drug

Vectura Inks Agreement To Support Kinaset Therapeutics For Asthma Drug

Read more
30 Nov 2020 08:06

Vectura signs asthma treatment deal with Kinaset

(Sharecast News) - Vectura has signed a global licence and development deal with Kinaset Therapeutics of the US for the development and commercialisation of the VR588 pan-JAK asthma treatment.

Read more
20 Nov 2020 08:34

Court denies GSK appeal in Vectura intellectual property dispute

(Sharecast News) - Inhalation-focussed contract design and manufacture organisation Vectura Group announced on Friday that the United States Court of Appeals for the Federal Circuit has denied GlaxoSmithKline's (GSK) motions for judgment as a matter of law, a new trial on infringement, and for a new trial on damages in litigation concerning Vectura's US patent 8303991.

Read more
19 Nov 2020 20:25

IN BRIEF: Vectura Notes US Court Denying GSK's Motions For New Trials

IN BRIEF: Vectura Notes US Court Denying GSK's Motions For New Trials

Read more
28 Sep 2020 15:53

UK EXECUTIVE CHANGE SUMMARY: Tracsis Appoints New Finance Chief

UK EXECUTIVE CHANGE SUMMARY: Tracsis Appoints New Finance Chief

Read more
22 Sep 2020 19:34

IN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback

IN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback

Read more
15 Sep 2020 17:22

Vectura Revenue Slips But Swings To First Half Profit

Vectura Revenue Slips But Swings To First Half Profit

Read more
14 Sep 2020 17:21

UK TRADING UPDATE SUMMARY: Henry Boot Unit In Voluntary Liquidation

UK TRADING UPDATE SUMMARY: Henry Boot Unit In Voluntary Liquidation

Read more
2 Sep 2020 19:36

TOP NEWS: ITV Bumped From FTSE 100 For B&M European Value Retail

TOP NEWS: ITV Bumped From FTSE 100 For B&M European Value Retail

Read more
7 Jul 2020 16:35

UK TRADING UPDATE SUMMARY: Retailer Sosandar In Quarterly Revenue Jump

UK TRADING UPDATE SUMMARY: Retailer Sosandar In Quarterly Revenue Jump

Read more
9 Jun 2020 12:04

DIRECTOR DEALINGS: Vectura Group Non-Exec Matthews Buys First Shares

DIRECTOR DEALINGS: Vectura Group Non-Exec Matthews Buys First Shares

Read more
8 Jun 2020 15:00

Vectura Inks Deal With Aerami To Develop Inhaled Imatinib

Vectura Inks Deal With Aerami To Develop Inhaled Imatinib

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.